HEALTH

News

Study results on a short-acting Insulin published

In a cooperative contract research project, HEALTH and Med Uni Graz have tested a new insulin in a clinical phase 1 study on behalf of Arecor.

HEALTH ist verantwortlich für die Insulinanalytik, die statistische Auswertung, das klinische Datenmanagement und das Qualitätsmanagement
Credit: JOANNEUM RESEARCH

The study, in which HEALTH was responsible for insulin analysis, statistical evaluation, clinical data management, and quality management, showed that the new insulin enters the bloodstream more quickly and thus also acts faster. As a result, blood glucose control in type 1 diabetics is optimized and dangerous hyper- and hypoglycemia can be avoided. The study results are now published in the top-ranking Journal Diabetes Care.

This new type of fast-acting insulin is an important step in the development of an artificial pancreas. HEALTH is proud to support our clients with new developments to further improve the lives of people with diabetes.

Further reading:

Link to paper in Diabetes Care

Our Service Portfolio

Link to Arecor

Link to Medical University of Graz